The proposed bill aims to prohibit pharmaceutical manufacturers from restricting or limiting the distribution of prescription medications to a limited network of out-of-state pharmacies. It introduces a new section to the Arkansas Code, which emphasizes the importance of patient access to prescription drugs and pharmacy services. The bill outlines that local pharmacies, clinics, and hospitals should have the ability to access medications without being hindered by out-of-state distribution networks, which may include mail-order pharmacies affiliated with pharmacy benefits managers, publicly traded corporations, or insurance companies. The legislation also highlights the need for transparency and oversight in the distribution process to ensure patient safety and timely access to medications.

Additionally, the bill mandates that pharmaceutical manufacturers must not limit access to their medications for more than three months after a new product launch without providing local pharmacies the opportunity to participate in the distribution network. It requires manufacturers to maintain an active wholesale distributor permit and comply with specific guidelines regarding access and patient management services. Noncompliance with these regulations could result in fines of $10,000 per day. The bill also includes a severability clause and sets a compliance deadline for manufacturers by September 1, 2026.